Sonoma Pharmaceuticals (SNOA) Prepaid Assets (2011 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly Prepaid Assets came in at $232000.0 in Q1 2026, down 84.85% year-on-year from $1.5 million in Q1 2025, and down 93.08% quarter-over-quarter from $3.4 million in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Prepaid Assets (2011 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Prepaid Assets history runs 16 years deep, the most recent figure standing at $232000.0 for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 84.85% year-over-year to $232000.0 in Q1 2026; TTM through Mar 2026 was $232000.0, a 84.85% decrease from a year earlier, with the FY2026 full-year figure at $232000.0, down 84.85% from the prior year.
- Prepaid Assets eased to $232000.0 in Q1 2026 per SNOA's latest filing, from $3.4 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $4.6 million in Q2 2023 and bottomed at $25000.0 in Q1 2023.
- The 5-year median for Prepaid Assets is $2.9 million (2025), against an average of $2.5 million.
- Across the five-year window, Prepaid Assets slumped 96.69% in 2023 and jumped 1358.1% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $3.2 million in 2022, then gained by 24.12% to $4.0 million in 2023, then plunged by 65.4% to $1.4 million in 2024, then surged by 141.6% to $3.4 million in 2025, then slumped by 93.08% to $232000.0 in 2026.
- Per Business Quant, the three latest SNOA Prepaid Assets figures stand at $232000.0 (Q1 2026), $3.4 million (Q4 2025), and $2.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 232,000.00 |
| Dec 31, 2025 | 3.35 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 105,000.00 |
| Dec 31, 2023 | 4.01 Mn |
| Sep 30, 2023 | 4.40 Mn |
| Jun 30, 2023 | 4.62 Mn |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | 3.23 Mn |
| Sep 30, 2022 | 3.32 Mn |
| Jun 30, 2022 | 3.79 Mn |
| Mar 31, 2022 | 755,000.00 |
| Dec 31, 2021 | 3.23 Mn |
| Sep 30, 2021 | 3.52 Mn |
| Jun 30, 2021 | 3.51 Mn |